// App-Quantinova.ai

P512 : Real world use of adalimumab: effects on corticosteroid treatment and hospital resource utilisation in UK patients with moderate/severe ulcerative colitis

Researchers

Presenter

  • G. Watts

Principal Investigators

  • R. Arasaradnam

  • S. Travis

  • A. Sharma

  • A. Awasthi

  • J. Limdi

  • A. Bishop-Bailey

  • S. Mclain-Smith

  • T. Finney-Hayward

Medical Centers

  • University of Manchester, Manchester, United Kingdom

  • University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United Kingdom

  • Walsall Healthcare NHS Trust, Walsall, United Kingdom

  • The Pennine Acute Hospitals NHS Trust, Crumpsall, United Kingdom

  • pH Associates Ltd, Marlow, United Kingdom

  • AbbVie, Inc, Maidenhead, IL, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved